The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential
Open accessAbstract
Embryo-derived tissues, such as umbilical cord (UC), can represent attractive sources of mesenchymal stem cells because their use is not related to any ethical issue. Abundant experimental evidence has already shown that Wharton's jelly contains cells able to differentiate in vitro into adipocytes, chondrocytes, osteocytes and neurons. Human UCs were obtained from term caesarean deliveries and processed within 24 h. Cells derived from the Wharton's jelly expressing mesenchymal markers, such as CD105, but not KDR and CD31 antigens, have been selected by positive and negative immunoseparation. These cells were characterized by an elongated shape and a good proliferation rate. Moreover, they were, at least in part, of fetal origin, as demonstrated by the expression of Sry mRNA. The expression of Myf5 and MyoD was detected after 7 and 11 days of in vitro myogenic induction, respectively. At two weeks from cell injection in the tibialis anterior muscle, previously damaged with bupivacaine, skeletal muscle appeared completely repaired and transplanted cells were present in the muscle for two weeks and differentiated into skeletal muscle cells, as demonstrated by the co-localization of HLA 1 and sarcomeric tropomyosine antigens. These observations provide the first demonstration that CD105(+)/CD31(-)/KDR(-) cells are able not only to differentiate in vivo towards the myogenic lineage, but also to contribute to the muscle regenerative process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Survival and Development of Neonatal Rat Cardiomyocytes Transplanted into Adult Myocardium
Müller-Ehmsen, J., Whittaker, P., Kloner, R. A., Dow, J. S., Sakoda, T., Long, T. I., Laird, P. W., & Kedes, L. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1491 · Cited by 481
Cited by
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population
Troyer, D. L., & Weiss, M. L. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0439 · Cited by 767
Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells
Weiss, M. L., Anderson, C., Medicetty, S., Seshareddy, K. B., Weiss, R. J., VanderWerff, I., Troyer, D., & McIntosh, K. R. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1028 · Cited by 613
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
Fan, X.-L., Zhang, Y., Li, X., & Fu, Q.-L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03454-6 · Cited by 535
Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility
Nagamura-Inoue, T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.195 · Cited by 476
Metadata
- Authors
- Conconi, M., Burra, P., Di Liddo, R., Calore, C., Turetta, M., Bellini, S., Bo, P., Nussdorfer, G., & Parnigotto, P.
- Venue
- International Journal of Molecular Medicine
- Publisher
- Spandidos Publications
- Published
- 2006-12-01
- Volume
- 18
- Issue
- 6
- Pages
- 1089-96
- ISSN
- 1107-3756 (ISSN-L)
- 1791-244X
- OpenAlex
- W2139779507
- Cited by
- 206
- References
- 2
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. https://app.cochat.ai/papers/10.3892/ijmm.18.6.1089
- The paper
- Conconi, M., Burra, P., Di Liddo, R., Calore, C., Turetta, M., Bellini, S., Bo, P., Nussdorfer, G., & Parnigotto, P. (2006). CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.18.6.1089
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.